Cara Therapeutics shares owned by State Street Corporation
Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Cara Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cara Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Cara Therapeutics by State Street Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $56k | 180k | 0.31 |
2024-06-30 | $47k | 181k | 0.26 |
2024-03-31 | $913k | 1.0M | 0.91 |
2023-12-31 | $759k | 1.0M | 0.74 |
2023-09-30 | $1.6M | 925k | 1.68 |
2023-06-30 | $2.6M | 920k | 2.83 |
2023-03-31 | $9.3M | 1.9M | 4.91 |
2022-12-31 | $19M | 1.8M | 10.74 |
2022-09-30 | $18M | 1.9M | 9.36 |
2022-06-30 | $18M | 2.0M | 9.13 |
2022-03-31 | $20M | 1.7M | 12.15 |
2021-12-31 | $18M | 1.5M | 12.18 |
2021-09-30 | $23M | 1.5M | 15.45 |
2021-06-30 | $23M | 1.6M | 14.27 |
2021-03-31 | $20M | 921k | 21.71 |
2020-12-31 | $15M | 963k | 15.13 |
2020-09-30 | $12M | 950k | 12.73 |
2020-06-30 | $17M | 1.0M | 17.10 |
2020-03-31 | $14M | 1.0M | 13.21 |
2019-12-31 | $16M | 1000k | 16.11 |
2019-03-31 | $35M | 1.8M | 19.62 |
2018-12-31 | $28M | 2.1M | 13.00 |
2018-09-30 | $51M | 2.1M | 23.95 |
2018-06-30 | $33M | 1.7M | 19.15 |
2018-03-31 | $33M | 2.6M | 12.38 |
2017-12-31 | $24M | 2.0M | 12.24 |
2017-09-30 | $49M | 3.6M | 13.69 |
2017-06-30 | $50M | 3.2M | 15.39 |
2017-03-31 | $7.6M | 413k | 18.39 |
2016-12-31 | $3.2M | 349k | 9.31 |
2016-09-30 | $2.7M | 325k | 8.36 |
2016-06-30 | $1.5M | 322k | 4.81 |
2016-03-31 | $2.0M | 324k | 6.23 |
2015-12-31 | $4.8M | 283k | 16.85 |
2015-09-30 | $3.7M | 261k | 14.28 |
2015-06-30 | $1.4M | 118k | 12.15 |
2015-03-31 | $959k | 96k | 10.04 |
2014-12-31 | $989k | 99k | 9.97 |
2014-09-30 | $847k | 101k | 8.40 |
2014-06-30 | $1.6M | 96k | 17.04 |
2014-03-31 | $647k | 35k | 18.64 |
Top funds holding Cara Therapeutics
View all funds holding Cara Therapeutics